Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study
- DOI
- 10.1182/bloodadvances.2026019931
- Published
- 2026-08-31
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026019931,
title = {Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study},
author = {Guy Young and Pantep Angchaisuksiri and Shashikant Apte and Renée Brown Frandsen and Anthony K. C. Chan and Pratima Chowdary and Hermann Eichler and Chuhl Joo Lyu and Maria Fernanda Martinez Garcia and Tadashi Matsushita and Sonata Šaulytė Trakymienė and Hyuen Tran and Alice Trinchero and Jerzy Windyga and Jan Astermark},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2026019931},
url = {https://doi.org/10.1182/bloodadvances.2026019931}
}RIS
TY - JOUR TI - Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study AU - Guy Young AU - Pantep Angchaisuksiri AU - Shashikant Apte AU - Renée Brown Frandsen AU - Anthony K. C. Chan AU - Pratima Chowdary AU - Hermann Eichler AU - Chuhl Joo Lyu AU - Maria Fernanda Martinez Garcia AU - Tadashi Matsushita AU - Sonata Šaulytė Trakymienė AU - Hyuen Tran AU - Alice Trinchero AU - Jerzy Windyga AU - Jan Astermark PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2026019931 UR - https://doi.org/10.1182/bloodadvances.2026019931 ER -
APA
Young, G., Angchaisuksiri, P., Apte, S., Frandsen, R. B., Chan, A. K. C., Chowdary, P., Eichler, H., Lyu, C. J., Garcia, M. F. M., Matsushita, T., Trakymienė, S. Š., Tran, H., Trinchero, A., Windyga, J., & Astermark, J. (2026). Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study. Blood Advances. https://doi.org/10.1182/bloodadvances.2026019931
Source records
- crossref · retrieved 2026-09-25T22:09:48.700Z